Ross A. Soo, Victor Ho-fun Lee, Daniel Shao-Weng Tan, Oscar J. Juan Vidal, Alexander I. Spira, Gonzalo Fernandez-Hinojal, Erika K. Keeton, Zhihui Sunny Yang, Shengting Li, Zhiying Cindy Xu, Jeffrey A. Jones, Helena Alexandra Yu, Zofia Piotrowska, Helena Yu, Danny Nguyen, Alexander Spira, John Wrangle, Vamsidhar Velcheti, Mark Socinski, Rachel Sanborn, Gregory Kalemkerian, Nashat Gabrail, Ho Fun Victor Lee, Gerrina Ruiter, Egbert Smit, Daniel Shao Weng Tan, Ross Lai Kit Soo, James Chih-Hsin Yang, Gee-Chen Chang, Tsung-Ying Yang, Chao-Hua Chiu, Haruyasu Murakami, Hiroshi Tanaka, Yasushi Goto, Nishino Kazumi, Ryo Ariyasu, Shigeki Umemura, Haruko Daga, Annalisa Fontana, Lorenzo Antonuzzo, Antonio Passaro, Oscar Jose Juan-Vidal, Mariano Provencio Pulla, Gonzalo Fernandez Hinojal, Manual Cobo Dols, Antonio Calles Blanco, Laura Mezquita Perez, Delvys Rodriguez Abreu, Enriqueta Felip Font, Maria Rosario Garcia Campelo, Ernesto Samuel Nadal Alforia, Tatiana Hernandez, Hyun Woo Lee, Se Hyun Kim, Byoung Yong Shim, Sang-We Kim, Sung Yong Lee, Young Saing Kim, Se-Hoon Lee, Ji-Youn Han. "Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00763